- Home
- AGM vs RCKT Comparison
AGM vs RCKT Comparison
Compare AGM & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGM
- RCKT
- Stock Information
- Founded
- AGM 1987
- RCKT 1999
- Country
- AGM United States
- RCKT United States
- Employees
- AGM N/A
- RCKT N/A
- Industry
- AGM Finance Companies
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- AGM Finance
- RCKT Health Care
- Exchange
- AGM Nasdaq
- RCKT Nasdaq
- Market Cap
- AGM 2.1B
- RCKT 264.0M
- IPO Year
- AGM N/A
- RCKT N/A
- Fundamental
- Price
- AGM $182.53
- RCKT $3.00
- Analyst Decision
- AGM Hold
- RCKT Buy
- Analyst Count
- AGM 1
- RCKT 13
- Target Price
- AGM $215.00
- RCKT $18.50
- AVG Volume (30 Days)
- AGM 168.0K
- RCKT 3.8M
- Earning Date
- AGM 08-04-2025
- RCKT 08-04-2025
- Dividend Yield
- AGM 3.38%
- RCKT N/A
- EPS Growth
- AGM N/A
- RCKT N/A
- EPS
- AGM 16.17
- RCKT N/A
- Revenue
- AGM $357,515,000.00
- RCKT N/A
- Revenue This Year
- AGM $9.70
- RCKT N/A
- Revenue Next Year
- AGM $8.26
- RCKT N/A
- P/E Ratio
- AGM $10.97
- RCKT N/A
- Revenue Growth
- AGM N/A
- RCKT N/A
- 52 Week Low
- AGM $159.64
- RCKT $2.19
- 52 Week High
- AGM $217.60
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- AGM 34.29
- RCKT 45.55
- Support Level
- AGM $197.38
- RCKT $2.76
- Resistance Level
- AGM $202.63
- RCKT $3.24
- Average True Range (ATR)
- AGM 5.13
- RCKT 0.19
- MACD
- AGM -1.35
- RCKT 0.17
- Stochastic Oscillator
- AGM 8.60
- RCKT 74.85
About AGM Federal Agricultural Mortgage Corporation
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.